Thyroid Cancer Clinical Trials in Shanghai, Shanghai Municipality
10 recruitingShanghai, Shanghai Municipality, China
Showing 1–10 of 10 trials
Recruiting
Not Applicable
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Pancreatic Neuroendocrine TumorMedullary Thyroid CancerAdrenal Cortical Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine21 enrolled1 locationNCT06141369
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Lung CancerPancreas CancerThyroid Cancer+1 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 3
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.144 enrolled35 locationsNCT06860971
Recruiting
Phase 2
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
Thyroid Cancer
Fudan University60 enrolled1 locationNCT07235566
Recruiting
Phase 4
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University800 enrolled8 locationsNCT06195228
Recruiting
Phase 2
Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
Fudan University40 enrolled1 locationNCT06970353
Recruiting
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Differentiated Thyroid Cancer
Shanghai 6th People's Hospital500 enrolled1 locationNCT06671184
Recruiting
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
Thyroid Cancer
Ruijin Hospital40 enrolled1 locationNCT06800768
Recruiting
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
Thyroid Cancer
Ruijin Hospital40 enrolled1 locationNCT06730529
Recruiting
Phase 2
Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer
Differentiated Thyroid Cancer
Fudan University32 enrolled1 locationNCT05989425